The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections

被引:160
|
作者
Zhai, Bing [1 ]
Wu, Cheng [1 ]
Wang, Linqi [1 ]
Sachs, Matthew S. [1 ]
Lin, Xiaorong [1 ]
机构
[1] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA
基金
美国国家卫生研究院;
关键词
SEROTONIN REUPTAKE INHIBITORS; OBSESSIVE-COMPULSIVE DISORDER; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; ANTIFUNGAL ACTIVITY; DRUG DEVELOPMENT; AMPHOTERICIN-B; FLUCONAZOLE; NEOFORMANS; TARGET;
D O I
10.1128/AAC.00212-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Therapeutic treatment for systemic mycoses is severely hampered by the extremely limited number of antifungals. The difficulty of treatment of fungal infections in the central nervous system is further compounded by the poor central nervous system (CNS) penetration of most antifungals due to the blood-brain barrier. Only a few fungistatic azole drugs, such as fluconazole, show reasonable CNS penetration. Here we demonstrate that sertraline (Zoloft), the most frequently prescribed antidepressant, displays potent antifungal activity against Cryptococcus neoformans, the major causative agent of fungal meningitis. In in vitro assays, this neurotropic drug is fungicidal to all natural Cryptococcus isolates tested at clinically relevant concentrations. Furthermore, sertraline interacts synergistically or additively with fluconazole against Cryptococcus. Importantly, consistent with our in vitro observations, sertraline used alone reduces the brain fungal burden at an efficacy comparable to that of fluconazole in a murine model of systemic cryptococcosis. It works synergistically with fluconazole in reducing the fungal burden in brain, kidney, and spleen. In contrast to its potency against Cryptococcus, sertraline is less effective against strains of Candida species and its interactions with fluconazole against Candida strains are often antagonistic. Therefore, our data suggest the unique application of sertraline against cryptococcosis. To understand the antifungal mechanisms of sertraline, we screened a whole-genome deletion collection of Saccharomyces cerevisiae for altered sertraline susceptibility. Gene ontology analyses of selected mutations suggest that sertraline perturbs translation. In vitro translation assays using fungal cell extracts show that sertraline inhibits protein synthesis. Taken together, our findings indicate the potential of adopting this antidepressant in treating cryptococcal meningitis.
引用
收藏
页码:3758 / 3766
页数:9
相关论文
共 50 条
  • [41] Promising therapeutic option for cutaneous plasmacytosis: 308-nm excimer lamp
    Omura, Reina
    Sowa-Osako, Junko
    Fukai, Kazuyoshi
    Kusutani, Nao
    Takeoka, Yasunobu
    Koh, Hideo
    Ohsawa, Masahiko
    Iwatsuki, Keiji
    Tsuruta, Daisuke
    Hamada, Toshihisa
    JOURNAL OF DERMATOLOGY, 2018, 45 (08): : E215 - E216
  • [42] Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma
    Mansour, Marc R.
    Look, A. Thomas
    CANCER CELL, 2011, 20 (05) : 559 - 561
  • [43] The chemoprophylactic and therapeutic action of a wide variety of chemical compounds on two neurotropic virus infections in mice
    Kramer, SD
    Geer, HA
    Szobel, DA
    JOURNAL OF IMMUNOLOGY, 1944, 49 (05): : 273 - 314
  • [44] Magnetic Drug Targeting as New Therapeutic Option for the Treatment of Biomaterial Infections
    Obermeier, A.
    Kuechler, S.
    Matl, F. D.
    Pirzer, T.
    Stemberger, A.
    Mykhaylyk, O.
    Friess, W.
    Burgkart, R.
    JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2012, 23 (18) : 2321 - 2336
  • [45] Anidulafungin-A New Therapeutic Option for Candida Infections in Liver Transplantation
    Sganga, G.
    Pepe, G.
    Cozza, V.
    Nure, E.
    Lirosi, M. C.
    Frongillo, F.
    Grossi, U.
    Bianco, G.
    Agnes, S.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (07) : 1982 - 1985
  • [46] Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia
    Li, Jie
    Xue, Liying
    Hao, Hongling
    Han, Yuxiang
    Yang, Jingci
    Luo, Jianmin
    ONCOLOGY REPORTS, 2012, 27 (02) : 461 - 466
  • [47] Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients
    Roch, Melanie
    Varela, Maria Celeste
    Taglialegna, Agustina
    Rosato, Adriana E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (01) : 126 - 134
  • [48] Antimicrobial Peptides as a new Promising Therapeutic Treatment against Bacterial Infections
    Kaconis, Y.
    Richter, W.
    Roessle, M.
    Heinbockel, L.
    Gutsmann, T.
    Brandenburg, K.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 302 : 52 - 52
  • [49] A Critical Review of Postbiotics as Promising Novel Therapeutic Agents for Clostridial Infections
    Ozma, Mahdi Asghari
    Fadaee, Manouchehr
    Hosseini, Hamideh Mahmoodzadeh
    Ataee, Mohammad Hossein
    Mirhosseini, Seyed Ali
    PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2025, 17 (02) : 656 - 667
  • [50] Dual inhibition with losartan and aliskiren: a promising therapeutic option for type 2 diabetic nephropathy?
    Guntram Schernthaner
    Nature Clinical Practice Nephrology, 2008, 4 : 656 - 657